These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 23243288)

  • 1. The myth of the second remission of acute leukemia in the adult.
    Forman SJ; Rowe JM
    Blood; 2013 Feb; 121(7):1077-82. PubMed ID: 23243288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of minimal residual disease before and after myeloablative hematopoietic cell transplantation for acute leukemia.
    Appelbaum FR
    Best Pract Res Clin Haematol; 2013 Sep; 26(3):279-84. PubMed ID: 24309531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome and Minimal Residual Disease Monitoring in Patients with t(16;21) Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
    Qin YZ; Chen Y; Xu LP; Wang Y; Zhang XH; Chen H; Zhao XS; Liu KY; Huang XJ
    Biol Blood Marrow Transplant; 2018 Jan; 24(1):163-168. PubMed ID: 28939454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
    Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience.
    Arellano ML; Langston A; Winton E; Flowers CR; Waller EK
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):116-23. PubMed ID: 17222760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dasatinib-induced complete molecular response after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to prior imatinib-containing regimen: a case report and discussion.
    Czyz A; Lewandowski K; Kroll R; Komarnicki M
    Med Oncol; 2010 Dec; 27(4):1123-6. PubMed ID: 19885746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia.
    Spinelli O; Peruta B; Tosi M; Guerini V; Salvi A; Zanotti MC; Oldani E; Grassi A; Intermesoli T; Micò C; Rossi G; Fabris P; Lambertenghi-Deliliers G; Angelucci E; Barbui T; Bassan R; Rambaldi A
    Haematologica; 2007 May; 92(5):612-8. PubMed ID: 17488684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT.
    Spyridonidis A; Labopin M; Schmid C; Volin L; Yakoub-Agha I; Stadler M; Milpied N; Socie G; Browne P; Lenhoff S; Sanz MA; Aljurf M; Mohty M; Rocha V;
    Leukemia; 2012 Jun; 26(6):1211-7. PubMed ID: 22290066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse.
    Kurosawa S; Yamaguchi T; Miyawaki S; Uchida N; Sakura T; Kanamori H; Usuki K; Yamashita T; Okoshi Y; Shibayama H; Nakamae H; Mawatari M; Hatanaka K; Sunami K; Shimoyama M; Fujishima N; Maeda Y; Miura I; Takaue Y; Fukuda T
    Haematologica; 2010 Nov; 95(11):1857-64. PubMed ID: 20634493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.
    Duval M; Klein JP; He W; Cahn JY; Cairo M; Camitta BM; Kamble R; Copelan E; de Lima M; Gupta V; Keating A; Lazarus HM; Litzow MR; Marks DI; Maziarz RT; Rizzieri DA; Schiller G; Schultz KR; Tallman MS; Weisdorf D
    J Clin Oncol; 2010 Aug; 28(23):3730-8. PubMed ID: 20625136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia.
    Ram R; Storb R; Sandmaier BM; Maloney DG; Woolfrey A; Flowers ME; Maris MB; Laport GG; Chauncey TR; Lange T; Langston AA; Storer B; Georges GE
    Haematologica; 2011 Aug; 96(8):1113-20. PubMed ID: 21508120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission.
    Weisdorf DJ; Millard HR; Horowitz MM; Hyare PS; Champlin R; Ho V; Mielcarek M; Rezvani A; Stockerl-Goldstein K; Khoury HJ; De Lima M; Saber W; Sandmaier B; Zhang MJ; Eapen M
    Cancer; 2017 Jun; 123(11):2025-2034. PubMed ID: 28117884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic Hematopoietic Cell Transplantation for Patients with Mixed Phenotype Acute Leukemia.
    Munker R; Brazauskas R; Wang HL; de Lima M; Khoury HJ; Gale RP; Maziarz RT; Sandmaier BM; Weisdorf D; Saber W;
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1024-1029. PubMed ID: 26903380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the detection of minimal residual disease for the prognosis and the choice of post-remission therapy of intermediate-risk acute myeloid leukemia without FLT3-ITD, NPM1 and biallelic CEBPA mutations.
    Zheng WS; Hu YL; Guan LX; Peng B; Wang SY
    Hematology; 2021 Dec; 26(1):179-185. PubMed ID: 33594943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia in Adults.
    Speziali C; Paulson K; Seftel M
    Curr Hematol Malig Rep; 2016 Jun; 11(3):175-84. PubMed ID: 26984203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapsed acute lymphoblastic leukemia: Is it crucial to achieve molecular remission prior to transplant?
    Eapen M
    Best Pract Res Clin Haematol; 2017 Dec; 30(4):317-319. PubMed ID: 29156202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggressive chemotherapy for acute leukemia relapsed after transplantation.
    Sica S; Salutari P; Di Mario A; D'Onofrio G; Etuk B; Leone G
    Leuk Lymphoma; 1994 Sep; 15(1-2):131-4. PubMed ID: 7858490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival in relapsed acute leukemia.
    Schneidawind C; Hagmaier V; Faul C; Kanz L; Bethge W; Schneidawind D
    Ann Hematol; 2018 Dec; 97(12):2491-2500. PubMed ID: 30066039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy followed by modified donor lymphocyte infusion as a treatment for relapsed acute leukemia after haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: superior outcomes compared with chemotherapy alone and an analysis of prognostic factors.
    Yan CH; Wang JZ; Liu DH; Xu LP; Chen H; Liu KY; Huang XJ
    Eur J Haematol; 2013 Oct; 91(4):304-14. PubMed ID: 23837640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute leukemia in adults].
    Eigendorff E; Hochhaus A
    Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.